Odense University Hospital is the largest and most specialized hospital in Southern Denmark. OUH is both Odense's and Funen's largest single workplace. It has a budget of 835 million Euro and has 11.000 employees.

There are 1,038 beds in Department of Endocrinology, Odense University Hospital.

During the past decade, Department of Endocrinology, Odense University Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Endocrinology, Odense University Hospital" #1 sponsor was "Odense University Hospital" with 24 trials, followed by "RSP Systems A/S" with 2 trials sponsored, "Marianne Andersen" with 1 trials sponsored, "René Klinkby Støving" with 1 trials sponsored and "Steen Bonnema" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Endocrinology, Odense University Hospital" #1 collaborator was "Odense University Hospital" with 2 trials as a collaborator, "University of Southern Denmark" with 2 trials as a collaborator, "AP Moeller Foundation" with 1 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator and "Department of Sports Science and Clinical Biomechanics, University of Southern Denmark" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Department of Endocrinology, Odense University Hospital" are "Polycystic Ovary Syndrome" (5 trials), "Bone Diseases" (2 trials), "Childhood Obesity" (2 trials), "Diabetes" (2 trials) and "Graves' Disease" (2 trials). Many other conditions were trialed in "Department of Endocrinology, Odense University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Endocrinology, Odense University Hospital" are "Drug" (9 trials), "Behavioral" (4 trials), "Procedure" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Methimazole" (3 trials), "Placebo" (2 trials), "An individual motivational intervention program to promote and maintain self-care behaviour" (1 trials), "Cipralex" (1 trials) and "Coronary catherization and stem cell infusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Endocrinology, Odense University Hospital" are 19 trials for "All" genders, 6 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Department of Endocrinology, Odense University Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Department of Endocrinology, Odense University Hospital, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Endocrinology, Odense University Hospital, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 6 trials that are defined as “Not Applicable".